pharmanaming.com

professional naming for the healthcare & pharma industry

by Globrands/Labbrand Group

Search

Putting our lives in their brands

3 min

Putting our lives in their brands

From www.theguardian.com What if brand loyalty was actually as serious as life and death? Nick Dutnall looks at how we might trust a brand with our lives As consumers we’re loyal to particular brands that play a role in our lives. Kevin Roberts, CEO at Saatchi and Saatchi, even goes as far as describing the brands we allow closest to us as “lovemarks” – brands that create “an intimate, emotional connection”. It’s a potent scenario that evokes brand loyalty of the highest orde

Making medicine emotional

2 min

Making medicine emotional

from www.mmm-online.com Since the birth of branding, and particularly in the advent of the “like,” people have been using brands as a means of self-expression. We create emotional ties to brand names because we identify not with just the product, but with what it represents—and how that reflects who we are to the world. Brands can personify a tangible thing into something powerfully intangible. A strong brand decommoditizes a commodity because it lives in our heads and in our

Jennifer McKenzie and Amy Dam / Bereskin &Parr LLP

2 min

Update on pharmaceutical brand name requirements in Canada

Sponsors filing a drug submission must also provide a brand name assessment as part of the drug safety and effectiveness evaluation. The objective of this assessment is to evaluate the potential for a proposed drug name to be confused with other authorized products in Canada with the aim of preventing medication errors. In an effort to standardize the brand name review process, Health Canada released a new Guidance Document for Industry – Review of Drug Brand Names, which rep

What's in a name? For drugs, a lot of Zs and Xs

Meg Tirrell | Eric Chemi | Mark Fahey / CBNC

4 min

What's in a name? For drugs, a lot of Zs and Xs

Farxiga. Hetlioz. Otezla. Zykadia. No, these are not the names of distant planets visited by the starship Enterprise. They're the brand names of medicines recently approved by the Food and Drug Administration. If it seems as if drug names have been getting weirder, it's because, in some cases, they have. And they're likely to continue to, as the FDA approves new medicines at record rates, and regulations require a certain degree of differentiation from both other drugs and re

Back-to-'Biogen' shift signals wider industry branding trend

By Beth Snyder Bulik / FiercePharmaMarketing

2 min

Back-to-'Biogen' shift signals wider industry branding trend

Biogen's ($BIIB) recent change back to its original name - from the decade-old merger name Biogen Idec - made sense in many ways. Along with the nod to its biotech founding heritage, most people already called the company simply "Biogen," anyway. But the switch to just Biogen also signaled a new direction for the company and recognized the new reality in pharma. Companies can no longer rely on one or two blockbuster drugs and product messaging to attract attention with consum

Cancer breakthroughs trigger big pharma interest in drugs and deals

Jennifer Rankin / The Guardian

3 min

Cancer breakthroughs trigger big pharma interest in drugs and deals

Companies are scrambling to get into the immunotherapy market, which experts think could eventually be worth up to £26bn a year in sales. The new generation of drugs hailed as a once-in-a-generation advance in treatment for cancer patients is also viewed as good news for the pharmaceutical industry – just when analysts had started to voice concerns that the pipeline of blockbuster treatments in development was starting to run dry. Immunotherapy treatments, which use the body’

Defining brands and why they are critical to success in healthcare.

By David Coleiro and Michael White / eye for

5 min

Defining brands and why they are critical to success in healthcare.

As we start our column in earnest, we thought we should perhaps state our position, be clear on some boundaries and definitions of what we mean by ‘brand’ and why we believe brand building in healthcare is critical to success. What are brands and why are they important? At its core, a brand is a promise made and importantly, an experience delivered to your customers. When well managed, it can be an emotional connection that is hard to break". A brand is not a product or a ser

The Science of Naming Drugs (Sorry, 'Z' Is Already Taken)

By Donald G. McNeil Jr. /

4 min

The Science of Naming Drugs (Sorry, 'Z' Is Already Taken)

Not only is the process of christening a new product a lot trickier than it sounds, the most obvious candidates can be the most perilous. When British drug regulators told doctors recently to stop writing prescriptions for six antidepressants for children under 18, the drugs in question sounded like a "Star Wars" cast list: Paxil, Effexor, Celexa, Lexapro, Luvox and Zoloft. (A seventh, Prozac, was approved.) It has often been noted that drug makers have favorite letters, and

Biosimilars: Making the most of an “inexact” science

by John Phillips, Director

3 min

Biosimilars: Making the most of an “inexact” science

There’s no question that biosimilars are a revolution in life sciences. The development of these complex medications made from living cells, blood, and tissue is a brave new world, especially for generic manufacturers who may have less experience with the process than the drug designers in many branded companies. More than $67 billion in global biologics value is expected to face biosimilar competition by 2020. As with most uncharted territory, however, generic and branded dr

India to open drugs database to global regulators

Raji Reddy Kesireddy / ETHealthworld.com

2 min

India to open drugs database to global regulators

India had exported medicines worth $15.2 billion (about Rs 97,000 crore) in 2014-15, an increase of 5% over the previous year’s figure. Drug regulators and retailers across the world will soon be able to access a large database that India is building on domestic pharmaceutical manufacturers. India has decided to throw open the database to global stakeholders following concerns over spurious drugs emanating from the country. The government had earlier introduced barcoding on

1

2 3

Featured Posts

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency

The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring...

How does the FDA 'approve' medical products?

How does the FDA 'approve' medical products?

You may have seen medical products that claim to be "FDA cleared," "FDA registered," "FDA listed" or "FDA approved" - but what do these...

The Secret Formula Behind Every Drug Name

The Secret Formula Behind Every Drug Name

Most people have no problem with famous names like Enbrel®, Prozac®, and Viagra®. But when it comes to understanding new drug names, such...

Branding and design in the medical/pharma industry

Branding and design in the medical/pharma industry

Communication is often seen as a touchy subject when it comes to the healthcare sector, given the tight regulations and fierce...

Pharma Brand Strategy 2.0

Learn about the building blocks of a great brand strategy that will have the potential to capture the full commercial value from a...

What Is an Active Pharmaceutical Ingredient (API)?

What Is an Active Pharmaceutical Ingredient (API)?

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination...

The Drug Naming Process

The Drug Naming Process

Drugs often have several names. A marketed drug may have up to four different types of names: a chemical name, a company name, a generic...

The twists and turns of naming diseases

The twists and turns of naming diseases

When a new disease is identified in a group of patients it needs a name so it can be described, researched and treated. But, unlike...

Branding: When One is Not Enough

Branding: When One is Not Enough

Launching a second brand is a marketing strategy to address an unmet need distinct from the current brand. In the pharmaceutical industry...

Liposomal medicine names to be changed to avoid errors

Liposomal medicine names to be changed to avoid errors

The EMA has requested that liposomal medication names be changed to avoid the risk of confusion. All marketing authorisation holders of...

The difference between pharmaceutical and biotechnology

The difference between pharmaceutical and biotechnology

While sitting in a meeting recently I was asked, 'what exactly is the difference between pharma and biopharma?' For most of us, we may...

Biosimilar names may affect pharmacist dispensing habits

Biosimilar names may affect pharmacist dispensing habits

How biosimilars are named could influence the willingness of pharmacists to substitute such drugs for more expensive biologics, a survey...

Branders give products an identity

Branders give products an identity

In the world of branding, there's a language all its own: Casodex, Grazax, Latisse, Symbicort and Vusion. Each one of those words is the...

The top 10 drugs of 2024

The top 10 drugs of 2024

EvaluatePharma analysts predict AbbVie's Humira will top pharma's sales charts in 2024, followed by Merck's Keytruda and Celgene's...

FDA Draft Guidance Requiring Distinct Naming for Biosimilars

FDA Draft Guidance Requiring Distinct Naming for Biosimilars

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency ATLANTA – The American College of Rheumatology (ACR) today...

A drug by any other name would work just as well — making sense of drug names

A drug by any other name would work just as well — making sense of drug names

How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare's play Romeo and Juliet,...

FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested

FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested

The U.S. Food and Drug Administration (Silver Spring, MD) has approved a pill that includes a sensor that digitally tracks if patients...

Can you teach old drugs new tricks?

Can you teach old drugs new tricks?

Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that...

'Accelerated approval' drugs: How well are they studied?

'Accelerated approval' drugs: How well are they studied?

When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and...

The FDA just approved the first direct competitor to a billion-dollar cancer drug

The FDA just approved the first direct competitor to a billion-dollar cancer drug

As it stands right now, biosimilars can't be used interchangeably with branded versions, meaning if you were to get a prescription for a...

Role of brand is 57% more likely to influence a recommendation compared to two years ago

A new report conducted by health branding agency InterbrandHealth measures the value that brands alone provide pharmaceutical companies....

What’s in a name? Billions of dollars in tech costs for biosimilars

What’s in a name? Billions of dollars in tech costs for biosimilars

A new US FDA guidance on how biological products licensed under the Public Health Service Act (PHS Act) need to be named is playing havoc...

How drug development is speeding up in the cloud

How drug development is speeding up in the cloud

Developing a drug from a promising molecule to a potential life-saver can take more than a decade and cost billions of dollars. Speeding...

Globalization in the pharmaceutical industry

Globalization in the pharmaceutical industry

Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch's publications...

Why Biosimilar Drug Names Contain Unhelpful Gibberish

Why Biosimilar Drug Names Contain Unhelpful Gibberish

Have you ever wondered how drugs are named? Is there ever a discernible meaning behind drug names? Who manages this mess anyway–drug...

Behind potent drug names, a complex mix of ingredients

Behind potent drug names, a complex mix of ingredients

Firms must navigate legal and linguistic hurdles for approval They are the public face of products that can take many years and hundreds...

Introducing The New Association For Accessible Medicines (AAM)

Introducing The New Association For Accessible Medicines (AAM)

The Generic Pharmaceutical Association (GPhA), the US largest trade group representing generic pharmaceutical and biosimilar companies,...

FDA Reiterates Decision on Suffixes in Biosimilar Naming

FDA Reiterates Decision on Suffixes in Biosimilar Naming

A Federal Register notice from FDA addressed comments on the guidance on Proprietary Naming of Biological Products and the agency’s...

Behind potent drug names, a complex mix of ingredients

Behind potent drug names, a complex mix of ingredients

Drug names start out as alien words: random collections of syllables that can sometimes seem almost as mind-boggling as the complicated...

New diagnostic name for stigmatizing term obesity

New diagnostic name for stigmatizing term obesity

The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) proposed Adiposity-Based Chronic...

The creative science of coining drug names

The creative science of coining drug names

With more than 30,000 proprietary drugs in the United States alone, coming up with a unique brand name is no easy task. Cialis, Eliquis,...

UK medicines regulation: responding to current challenges

UK medicines regulation: responding to current challenges

The medicines regulatory environment is evolving rapidly in response to the changing environment. Advances in science and technology have...

Probiotics in Favor of Life

Probiotics in Favor of Life

We all use the term “probiotic" so often, but may not think of what it means. The Russian Nobel Laureate Elie Metchnikoff, best known for...

Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry

Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry

The rise of global consumerism has shifted the healthcare landscape tremendously. People expect sophisticated levels of transparency and...

'Creation engineering': The art and science of naming drugs

'Creation engineering': The art and science of naming drugs

CNN)Yearly lists of the "most popular baby names" show how tastes change over time. While Jennifer, Heather, Michael and Jason may have...

Neuropathy: A name for their pain

Neuropathy: A name for their pain

People with neuropathic pain have struggled to find relief with conventional drugs. Researchers are investigating whether more meaningful...

FDA approves first automated insulin delivery device for type 1 diabetes

FDA approves first automated insulin delivery device for type 1 diabetes

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device...

How drug startups choose their brand

The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech...

Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Joint venture will research diabetes treatments Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, will be CEO of the...

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

61% of patients reported that they were likely to ask for a specific prescription medication by name, implying research prior to...

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

Tracking and tracing the use of all biologics, including biosimilars, enhances patient safety. Where there are multiple companies...

Name that drug

Name that drug

The role of the European Medicines Agency (EMA) as a regulator is to protect and promote public and animal health by evaluating and...

What's the Prescription for a Perfect Name?

What's the Prescription for a Perfect Name?

With Viagra and Prozac rivaling McDonald's and Coca-Cola among today's most frequently used brand names, it's no surprise that...

EGA Becomes Medicines for Europe

EGA Becomes Medicines for Europe

The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued...

Hanmi's $200M China plant likely to make branded drugs versus generics

Hanmi's $200M China plant likely to make branded drugs versus generics

South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently,...

Top three therapy areas dominate pipelines

Top three therapy areas dominate pipelines

The world's top three therapy areas accounted for 68 percent of the overall pharmaceutical industry pipeline as of Q1 2016, according to...

GSK teams up with Google on bioelectronic medicines

GSK teams up with Google on bioelectronic medicines

GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic...

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the...

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace....

With a Name Like Xalkori

With a Name Like Xalkori

New drug names aren’t just bizarre—they’re dangerous. What would Don Draper make of Xalkori? Pfizer’s lung cancer drug, released in 2011,...

Recent Posts

The Secret Formula Behind Every Drug Name

The Drug Naming Process

Archive

Search By Tags